UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 1326, 2025

BREEZE HOLDINGS ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Delaware		001-39718		85-1849315
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification Number)

955 W. John Carpenter Freeway, Suite 100-929
Irving, TX 75039

(Address of principal executive offices)

(888) 273-9001

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

☐☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 par value per share	BRZH	OTCQX tier of the OTC Markets Group Inc.
Rights exchangeable into one-twentieth of one share of common stock	BRZHR	~~OTCQX~~OTCQB tier of the OTC Markets Group Inc.
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per whole share	BRZHW	~~OTCQX~~OTCQB tier of the OTC Markets Group Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 35.~~01.~~07 ~~Notice~~Submission of ~~Delisting~~Matters ~~or Failure~~ to ~~Satisfy~~ a ~~Continued~~Vote ~~Listing Rule or Standard; Transfer~~ of ~~Listing~~Security Holders.

OnA ~~March~~Special ~~17,~~Meeting ~~2025,~~of ~~Breeze~~Stockholders ~~Holdings Acquisition Corp.~~ (the “~~Company~~Special Meeting”) ~~was notified by OTC Markets Group Inc. that, as~~ of ~~such date,~~Breeze ~~its~~Holdings ~~publicly~~Acquisition traded warrants (BRZHW) and publicly traded rights (BRZHR) no longer satisfy the continued qualification requirements for the OTCQX Market, as set forth in Section 2 of the Requirements for Continued Qualification of the OTCQX Rules for UCorp.S. ~~Companies, which requires compliance with Section 1.1~~(~~A) of~~ the ~~OTCQX Eligibility Criteria, requiring the~~ “Company ~~to have (1~~”) ~~net tangible assets~~ ofwas ~~$2,000,000,~~held ifvia ~~the~~webcast ~~Company~~on ~~has~~June ~~been in continuous operation for at least three years~~26, ~~or $5~~2025,~~000,000,~~ ~~if the Company has been in continuous operation for less than three years; (2) average revenue of~~ at ~~least~~10:00 ~~$6,000,000~~a.m. ~~for~~Eastern ~~the~~Time. ~~last~~The ~~three~~number ~~years; or (3) a bid price~~ of $5shares ~~per share as~~ of ~~the~~common ~~close~~stock ofthat ~~business~~voted on ~~each~~matters ~~of the 30 consecutive calendar days immediately preceding the Company’s application day,~~presented ~~and as of the most recent fiscal year end have~~ at ~~least one of~~ the ~~following:~~Special ~~(A)~~Meeting ~~net~~was ~~income of $500~~3,~~000; (B) net tangible assets of $1~~179,~~000~~582,~~000; (C)~~ ~~revenues~~representing ~~of $~~93.2~~,000,000;~~% ~~or (D) total assets~~ of $5the 3,~~000~~412,~~000.~~103 Asshares ~~previously~~of ~~disclosed~~common instock ~~the~~issued ~~Company’s~~and ~~Form~~outstanding, ~~8-K~~and ~~filed on March~~entitled ~~19,~~to ~~2025,~~vote ~~and~~as ~~amended~~of onJune ~~March 21~~2, 2025, the ~~Company~~record ~~had~~date ~~been~~for ~~provided a 90-day cure period to address~~ the ~~deficiency.~~Special ~~The cure period has now lapsed without resolution~~Meeting.

AsEach aof ~~result,~~the proposals described below was approved by the Company’s ~~has~~stockholders ~~elected~~of torecord. ~~transition~~In connection with the ~~trading~~special meeting, 47,690 shares of ~~its~~the ~~warrants~~Company’s ~~and~~common ~~rights~~stock towere redeemed (the ~~OTCQB~~“Redemption”), ~~where~~with ~~they~~3,364,413 shares of Common Stock remaining outstanding after the Redemption; 224,413 shares of Common Stock remaining outstanding after the Redemption are ~~expected~~shares issued in connection with our initial public offering (the “Public Shares”). Our public stockholders will continue to ~~begin~~have ~~trading~~the onopportunity ~~June~~to 16redeem all or a portion of their Public Shares upon the completion of our initial business combination at a per-share price, ~~2025~~payable ~~and~~in cash, equal to ~~continue~~the aggregate amount on deposit in the trust account as of two business days prior to bethe ~~quoted~~vote ~~and~~to ~~traded~~approve the ~~thereafter~~consummation ~~without~~of ~~interruption.~~our ~~The~~initial ~~Company’s~~business ~~common~~combination, ~~stock~~including interest (~~BRZH~~which interest shall be net of taxes payable) divided by the ~~will~~number ~~continue~~of tothen ~~trade~~outstanding onPublic Shares, subject to the ~~OTCQX~~limitations described herein.

~~Item~~Following 8the Redemption, approximately $2.~~01.~~75 ~~Other~~million ~~Events~~remains on deposit in our trust account.

~~The~~If we are unable to complete an initial business combination on or before September 26, 2025 (unless the stockholders approve a further amendment to the Company’s isamended ~~continuing~~and restated certificate of incorporation to ~~pursue~~extend the ~~completion~~date by which the Company has to consummate a business combination), we will: (i) cease all operations except for the purpose of ~~its~~winding ~~proposed~~up, (ii) as promptly as reasonably possible but not more than ten business ~~combination~~days ~~with~~thereafter, YDredeem ~~Biopharma~~the ~~Limited~~Public ~~and~~Shares, ~~expects~~at ~~that~~a per-share price, payable in cash, equal to the ~~transition~~aggregate amount then on deposit in the trust account, including interest (which interest shall be net of ~~its~~taxes ~~warrants~~payable, and ~~rights~~less up to ~~OTCQB~~$100,000 of interest to pay dissolution expenses) divided by the number of then outstanding Public Shares, which redemption will ~~not~~completely ~~affect~~extinguish public stockholders’ rights as stockholders (including the ~~timing~~right orto ~~execution~~receive offurther liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such ~~plans~~redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

~~SIGNATURE~~1

~~Pursuant~~The following tois ~~the~~a ~~requirements~~list of ~~the~~ ~~Securities~~matters ~~Exchange~~considered ~~Act~~and ofapproved ~~1934,~~by the ~~registrant~~Company’s ~~has~~stockholders ~~duly~~at ~~caused this report to be signed on its behalf by~~ the ~~undersigned~~Special ~~hereunto duly authorized.~~Meeting:

~~BREEZE~~1. ~~HOLDINGS~~To ~~ACQUISITION~~amend ~~CORP.~~the ~~By: /~~Company’s/ J.amended ~~Douglas~~and ~~Ramsey~~restated ~~Name:~~certificate J.of ~~Douglas~~incorporation ~~Ramsey~~to ~~Title:~~extend ~~Chief~~the ~~Executive~~date ~~Officer~~by which the Company must consummate a business combination or, if it fails to do so, cease its operations and ~~Chief~~redeem ~~Financial~~or ~~Officer~~repurchase 100% of the shares of the Company’s common stock issued in the Company’s IPO, from June 26, 2024 monthly for up to three additional months at the election of the Company, ultimately until as late as September 26, 2025.

~~Dated~~Votes For: ~~June~~3,178,527 13Votes Against: 1,045 ~~2025~~Votes Withheld: 10

To amend the Investment Management Trust Agreement, dated November 23, 2020, (the “Trust Agreement”), by and between the Company and Continental Stock Transfer & Company (the “Trustee”), pursuant to an amendment to the Trust Agreement, to authorize the Extension and its implementation by the Company.

Votes For:

3,178,526

Votes Against:

1,045

Votes Withheld:

To approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposals 1 or 2.

Following the Special Meeting, the Company filed an amendment to its amended and restated certificate of incorporation with the State of Delaware, a copy of which is attached as Exhibit 3.1 to this Current Report.

Votes For:

3,178,506

Votes Against:

1,050

Votes Withheld:

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

3.1

Seventh Amendment to Amended and Restated Certificate of Incorporation of Breeze Holdings Acquisition Corp., dated June 26, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BREEZE HOLDINGS ACQUISITION CORP.

By:	/s/ J. Douglas Ramsey
Name:	J. Douglas Ramsey
Title:	Chief Executive Officer and Chief Financial Officer

Dated: June 27, 2025

Filing Compare · Breeze Holdings Acquisition Corp.